结果代偿性肝硬化组服用软肝片后效果明显，失代偿性肝硬化组无明显疗效。
Results the curative effect on the compensatory cirrhosis treated group was significantly better than the decompensated cirrhosis group.
目的研究结肠灌注透析对失代偿性肝硬化顽固性腹水及内毒素血症、高氨血症、低钠血症的治疗效果。
Objective to study the curative effect of the colon perfusion dialysis for the decompensated hepatocirrhosis with intractable ascites, endotoxemia, hyperammonemia and hyponatremia.
结论结肠灌注透析治疗对失代偿性肝硬化顽固性腹水及内毒素血症、高氨血症、低钠血症均有较好的近期疗效。
Conclusion Colon perfusion dialysis therapy had good short-term effect on the decompensated hepatocirrhosis with intractable ascites, endotoxemia, hyperammonemia and hyponatremia.
失代偿性肝硬化的患病率根据患者的年龄而变化，并且每年增加约2%，但是仅在60岁以上的患者中观察到这一比率的增加更显著。
The prevalence of decompensated cirrhosis varied according to the age of patients and increased by about 2 percent a year, but the increase was seen only in patients over age 60.
结论：失代偿性肝硬化患者因纤维蛋白原浓度下降致使纤维蛋白单体聚合功能降低，从而出现低凝状态，这可能是构成出血倾向的原因之一。
Conclusion: Plasma Fbg concentration and fibrin monomer polymerize function were decrease, showed that patients were low coagulation state and contributing to one cause of hemorrhage.
目的：对相关文献进行一项系统综述，来确定HCV相关性代偿期肝硬化的结局。
Aim to perform a systematic review of the literature to establish the outcome of compensated HCV cirrhosis.
目的探讨肝硬化失代偿期合并肝性胸水患者的临床特点。
Objective To investigate the clinical features of decompensate cirrhosis patients with pleural effusion.
目的：探讨肝硬化失代偿期并发自发性细菌性腹膜炎(SBP)危险因素，提高早期诊断率。
AIM: to investigate the risk factors of decompensated cirrhosis complicated with spontaneous bacterial peritonitis (SBP), and to improve the rate for early diagnosis rate.
目的：观察二甲胶囊抗肝纤维化、治疗肝硬化(代偿期)的临床疗效和安全性。
Objective: To observe clinical effect and safety that Erjia capsule treated cirrhosis of liver.
方法对67例失代偿肝硬化并发肺部感染患者的临床资料进行了回顾性分析。
Methods a retrospective analysis was made in 67 cases with decompensated cirrhosis suffered from the pulmonary infection.
方法：对酒精性肝硬化代偿期和失代偿期患者及健康者用放射免疫分析法检测细胞因子的含量进行分析。
Methods: The changes in serum cytokine level in compensated and decompensated alcoholic liver cirrhosis patients and healthy controls were measured by radioimmunoassay technique.
结果肝硬化代偿期组患者的血糖及胰岛素水平与正常对照组比较差异无显著性（P>0.05）；
Results The blood sugar and insulin levels in patients with compensatory phase were almost the same with those in the control group, there were no statistically significant difference (P>0.05);
结果肝硬化代偿期组患者的血糖及胰岛素水平与正常对照组比较差异无显著性（P>0.05）；
Results The blood sugar and insulin levels in patients with compensatory phase were almost the same with those in the control group, there were no statistically significant difference (P>0.05);
应用推荐